Annual CFO
Summary
- Current Value
- As of today, MRNA annual cash from operations is -$3.00B, up +3.66% on
- Historical Performance
- MRNA annual cash from operations is down -122.06% over the past 3 years, and down -554.47% over the past 5 years
- All-Time High Comparison
- MRNA annual cash from operations is currently -122.06% below its historical high of $13.62B set on
- 3-Year Low Comparison
- MRNA annual cash from operations is +3.66% above its 3-year low of -$3.12B reached on
- Sector Comparison
- MRNA annual cash from operations is higher than 0.08% of companies in Healthcare sector
Cash From Operations Chart
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Cash From Operations | -$3.00B | +3.7% | -122.1% | -554.5% | -10000.0% | |
| Quarterly Cash From Operations | -$847.00M | +45.9% | -436.1% | -194.9% | -10000.0% | |
| TTM Cash From Operations | -$1.98B | +38.3% | -129.8% | -397.6% | -10000.0% | |
| Price | $33.84 | -19.9% | -82.0% | -72.8% | – | |
| Annual Cash From Investing | $1.95B | -53.7% | +122.9% | +10000.0% | +10000.0% | |
| Annual Cash From Financing | $56.00M | +104.1% | +106.4% | +7.7% | +1053.7% | |
| Annual Free Cash Flow | -$4.06B | -6.0% | -130.4% | -725.9% | -10000.0% | |
| Annual CAPEX | $1.05B | +48.7% | +270.1% | +3230.8% | +10000.0% | |
| Annual Net Income | -$3.56B | +24.5% | -129.2% | -592.8% | -10000.0% |
Cash From Operations Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $4.98B | N/A | -160.3% |
| 5Y | $13.62B | -122.1% | |
| All | $13.62B | -122.1% |
Cash From Operations Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$3.12B | +3.7% | |
| 5Y | -$3.12B | +3.7% | |
| All | -$3.12B | +3.7% |
Cash From Operations History
FAQ
What is the current annual cash from operations of MRNA?
As of today, MRNA annual cash from operations is -$3.00B
What is 1-year change in MRNA annual cash from operations?
MRNA annual cash from operations is up +3.66% year-over-year
What is 3-year change in MRNA annual cash from operations?
MRNA annual cash from operations is down -122.06% over the past 3 years
How far is MRNA annual cash from operations from its all-time high?
MRNA annual cash from operations is currently -122.06% below its historical high of $13.62B set on December 31, 2021
How does MRNA annual cash from operations rank versus sector peers?
MRNA annual cash from operations is higher than 0.08% of companies in Healthcare sector
When is MRNA next annual earnings release?
The next annual earnings release for MRNA is on
Quarterly CFO
Summary
- Current Value
- As of today, MRNA quarterly cash from operations is -$847.00M, up +7.83% on
- Historical Performance
- MRNA quarterly cash from operations is up +45.91% year-over-year, and down -436.11% over the past 3 years
- All-Time High Comparison
- MRNA quarterly cash from operations is currently -120.85% below its historical high of $4.06B set on
- 3-Year Low Comparison
- MRNA quarterly cash from operations is +47.06% above its 3-year low of -$1.60B reached on
- Sector Comparison
- MRNA quarterly cash from operations is higher than 0.18% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Cash From Operations | -$847.00M | +7.8% | +45.9% | -436.1% | -194.9% | |
| Annual Cash From Operations | -$3.00B | – | +3.7% | -122.1% | -554.5% | |
| TTM Cash From Operations | -$1.98B | +26.7% | +38.3% | -129.8% | -397.6% | |
| Price | $33.84 | +26.1% | -19.9% | -82.0% | -72.8% | |
| Quarterly Cash From Investing | $700.00M | +24.1% | -2.9% | -25.9% | +159.4% | |
| Quarterly Cash From Financing | -$1.00M | -111.1% | -109.1% | +99.9% | -103.4% | |
| Quarterly Free Cash Flow | -$880.00M | +4.6% | +48.8% | -639.9% | -200.8% | |
| Quarterly CAPEX | $33.00M | +1000.0% | -78.2% | -62.9% | +71.1% | |
| Quarterly Net Income | -$200.00M | +75.8% | -1638.5% | -119.2% | +14.4% |
Quarterly Cash From Operations Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $825.00M | N/A | -202.7% |
| 3Y | $1.66B | N/A | -151.0% |
| 5Y | $4.06B | -120.8% | |
| All | $4.06B | -120.8% |
Quarterly Cash From Operations Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$1.04B | +18.3% | |
| 3Y | -$1.60B | +47.1% | |
| 5Y | -$1.60B | +47.1% | |
| All | -$1.60B | +47.1% |
Quarterly Cash From Operations History
FAQ
What is the current quarterly cash from operations of MRNA?
As of today, MRNA quarterly cash from operations is -$847.00M
What is MRNA quarterly cash from operations most recent change?
MRNA quarterly cash from operations was up +7.83% on September 30, 2025
What is 1-year change in MRNA quarterly cash from operations?
MRNA quarterly cash from operations is up +45.91% year-over-year
How far is MRNA quarterly cash from operations from its all-time high?
MRNA quarterly cash from operations is currently -120.85% below its historical high of $4.06B set on June 30, 2021
How does MRNA quarterly cash from operations rank versus sector peers?
MRNA quarterly cash from operations is higher than 0.18% of companies in Healthcare sector
When is MRNA next earnings release?
The next earnings release for MRNA is on
TTM CFO
Summary
- Current Value
- As of today, MRNA TTM cash from operations is -$1.98B, up +26.66% on
- Historical Performance
- MRNA TTM cash from operations is up +38.32% year-over-year, and down -129.84% over the past 3 years
- All-Time High Comparison
- MRNA TTM cash from operations is currently -114.52% below its historical high of $13.62B set on
- 3-Year Low Comparison
- MRNA TTM cash from operations is +38.97% above its 3-year low of -$3.24B reached on
- Sector Comparison
- MRNA TTM cash from operations is higher than 0.09% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM Cash From Operations | -$1.98B | +26.7% | +38.3% | -129.8% | -397.6% | |
| Annual Cash From Operations | -$3.00B | – | +3.7% | -122.1% | -554.5% | |
| Quarterly Cash From Operations | -$847.00M | +7.8% | +45.9% | -436.1% | -194.9% | |
| Price | $33.84 | +26.1% | -19.9% | -82.0% | -72.8% | |
| TTM Cash From Investing | $1.46B | -1.4% | -25.4% | +127.6% | +207.7% | |
| TTM Cash From Financing | $9.00M | -57.1% | +118.0% | +100.2% | -99.5% | |
| TTM Free Cash Flow | -$2.66B | +23.9% | +32.7% | -142.9% | -533.8% | |
| TTM CAPEX | $685.00M | -14.7% | -8.5% | +60.0% | +1248.2% | |
| TTM Net Income | -$3.12B | -7.3% | -40.1% | -126.5% | -420.4% |
TTM Cash From Operations Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$1.98B | at high | |
| 3Y | $4.98B | N/A | -139.7% |
| 5Y | $13.62B | -114.5% | |
| All | $13.62B | -114.5% |
TTM Cash From Operations Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$3.05B | +35.2% | |
| 3Y | -$3.24B | +39.0% | |
| 5Y | -$3.24B | +39.0% | |
| All | -$3.24B | +39.0% |
TTM Cash From Operations History
FAQ
What is the current TTM cash from operations of MRNA?
As of today, MRNA TTM cash from operations is -$1.98B
What is MRNA TTM cash from operations most recent change?
MRNA TTM cash from operations was up +26.66% on September 30, 2025
What is 1-year change in MRNA TTM cash from operations?
MRNA TTM cash from operations is up +38.32% year-over-year
How far is MRNA TTM cash from operations from its all-time high?
MRNA TTM cash from operations is currently -114.52% below its historical high of $13.62B set on December 31, 2021
How does MRNA TTM cash from operations rank versus sector peers?
MRNA TTM cash from operations is higher than 0.09% of companies in Healthcare sector
When is MRNA next earnings release?
The next earnings release for MRNA is on
Cash From Operations Formula
Data Sources & References
- MRNA Official Website www.modernatx.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1682852/000168285225000075/0001682852-25-000075-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1682852/000168285225000022/0001682852-25-000022-index.htm
- MRNA Profile on Yahoo Finance finance.yahoo.com/quote/MRNA
- MRNA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/mrna
